Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Mesa Biotech Opens Manufacturing Facility to Meet Flu Diagnosis Needs

By Mesa Biotech Inc. | December 5, 2018

Mesa Biotech Inc., a molecular diagnostic company that developed a polymerase chain reaction testing platform designed specifically for point-of-care, has completed a major expansion of its San Diego manufacturing facility, increasing the facility footprint by 68 percent and enabling the company to produce millions of flu tests annually.

Polymerase chain reaction now is a widely used molecular biology to make millions of copies of specific DNA segments. 

Mesa Biotech manufactures the Accula Flu A/Flu B Test and the Accula RSV Test that have both obtained CE Mark in the EU and 510(k) clearance and Clinical Laboratory Improvements Amendments (CLIA) waiver from the U.S. Food and Drug Administration (FDA) this year. Both products are distributed in the U.S. and Canada by Sekisui Diagnostics under the Silaris brand and via a number of strategic distribution agreements in Europe and Asia.

“The timing for completion of the facility is optimal,” Hong Cai, co-founder and chief executive officer, Mesa Biotech, Inc. “As we enter the coming flu season, our new facility will provide manufacturing capacity to support the diagnostic needs of physicians, enabling them to administer accurate and timely treatment to their patients.”  

The expanded facility incorporates infrastructure and equipment to enhance productivity, collaboration, and innovation. The expansion also nearly doubles Mesa’s workforce, with the addition of engineering, product development, and manufacturing positions.

(Source: Mesa Biotech Inc. via PR Newswire)

Related Articles Read More >

Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
Prolific Machines logo.
Prolific Machines enters FDA program to enhance therapeutics manufacturing platform
Genentech roche
Roche, Genentech to build $700M drug manufacturing plant in North Carolina
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE